Imlifidase for hematologists: Creating a therapeutic window in the presence of neutralizing alloantibodies

Research output: Contribution to journal › Article › Academic › peer-review

Access to Document

@article{13dfc47d093d406b933f3bdb17b624ab,

title = "Imlifidase for hematologists: Creating a therapeutic window in the presence of neutralizing alloantibodies",

author = "Schutgens, {Roger E G}",

year = "2024",

month = jan,

doi = "10.1002/hem3.37",

language = "English",

volume = "8",

journal = "Hemasphere",

issn = "2572-9241",

publisher = "Wolters Kluwer Health",

number = "1",

}

TY - JOUR

T1 - Imlifidase for hematologists

T2 - Creating a therapeutic window in the presence of neutralizing alloantibodies

AU - Schutgens, Roger E G

PY - 2024/1

Y1 - 2024/1

UR - http://www.scopus.com/inward/record.url?scp=85187865138&partnerID=8YFLogxK

U2 - 10.1002/hem3.37

DO - 10.1002/hem3.37

M3 - Article

C2 - 38434531

SN - 2572-9241

VL - 8

JO - Hemasphere

JF - Hemasphere

IS - 1

M1 - e37

ER -